Novel expression of Neuropilin 1 on human tumor-infiltrating lymphocytes in colorectal cancer liver metastases

Belal Chaudhary, Eyad Elkord

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Objectives: Neuropilin 1 (NRP1) is a transmembrane protein with diverse roles in physiological and pathological settings. NRP1 expression has been reported on T cells in inflammatory microenvironments and in secondary lymphoid tissue. Tumor-infiltrating lymphocytes (TILs) play an important role in cancer prognosis. In this study, we investigated NRP1 expression on TILs and peripheral blood mononuclear cells (PBMCs) from colorectal cancer liver metastases (LI/CRC). Methods: TILs from LI/CRC and PBMCs from healthy donors and patients were analyzed for expression of NRP1, in addition to other Treg-related markers. PBMCs were co-cultured in vitro with tumor tissue and analyzed for NRP1 expression. Results: We report for the first time that NRP1 is highly expressed on CD3+CD4+ TILs compared to PBMCs. NRP1 expression correlated closely with CD25 expression in TILs. NRP1 was expressed on both Helios+ and Helios- FoxP3-expressing Tregs and on a FoxP3-Helios- T cell subset. It was also induced on PBMCs following in vitro co-culture with tumor tissue. Conclusions: NRP1 is upregulated on TILs and can be induced on PBMCs by tumor tissue. Further studies are warranted to define the function of NRP1 on human TILs. As a therapeutic target, NRP1 may allow selective targeting of TIL subsets including suppressive Tregs.

Original languageEnglish
Pages (from-to)147-161
Number of pages15
JournalExpert Opinion on Therapeutic Targets
Volume19
Issue number2
DOIs
Publication statusPublished - 1 Feb 2015
Externally publishedYes

Fingerprint

Neuropilin-1
Tumor-Infiltrating Lymphocytes
Lymphocytes
Liver Neoplasms
Liver
Tumors
Colorectal Neoplasms
Neoplasm Metastasis
Blood Cells
Blood
Tissue
T-cells
Neoplasms
Lymphocyte Subsets
T-Lymphocyte Subsets
Lymphoid Tissue
Coculture Techniques

Keywords

  • Colorectal cancer liver metastases
  • Expression
  • Neuropilin 1
  • Regulatory T cells
  • Tumor-infiltrating lymphocytes

ASJC Scopus subject areas

  • Drug Discovery
  • Pharmacology
  • Clinical Biochemistry
  • Molecular Medicine
  • Medicine(all)

Cite this

Novel expression of Neuropilin 1 on human tumor-infiltrating lymphocytes in colorectal cancer liver metastases. / Chaudhary, Belal; Elkord, Eyad.

In: Expert Opinion on Therapeutic Targets, Vol. 19, No. 2, 01.02.2015, p. 147-161.

Research output: Contribution to journalArticle

@article{18b140e4150e4cda8d0e395a813b18a9,
title = "Novel expression of Neuropilin 1 on human tumor-infiltrating lymphocytes in colorectal cancer liver metastases",
abstract = "Objectives: Neuropilin 1 (NRP1) is a transmembrane protein with diverse roles in physiological and pathological settings. NRP1 expression has been reported on T cells in inflammatory microenvironments and in secondary lymphoid tissue. Tumor-infiltrating lymphocytes (TILs) play an important role in cancer prognosis. In this study, we investigated NRP1 expression on TILs and peripheral blood mononuclear cells (PBMCs) from colorectal cancer liver metastases (LI/CRC). Methods: TILs from LI/CRC and PBMCs from healthy donors and patients were analyzed for expression of NRP1, in addition to other Treg-related markers. PBMCs were co-cultured in vitro with tumor tissue and analyzed for NRP1 expression. Results: We report for the first time that NRP1 is highly expressed on CD3+CD4+ TILs compared to PBMCs. NRP1 expression correlated closely with CD25 expression in TILs. NRP1 was expressed on both Helios+ and Helios- FoxP3-expressing Tregs and on a FoxP3-Helios- T cell subset. It was also induced on PBMCs following in vitro co-culture with tumor tissue. Conclusions: NRP1 is upregulated on TILs and can be induced on PBMCs by tumor tissue. Further studies are warranted to define the function of NRP1 on human TILs. As a therapeutic target, NRP1 may allow selective targeting of TIL subsets including suppressive Tregs.",
keywords = "Colorectal cancer liver metastases, Expression, Neuropilin 1, Regulatory T cells, Tumor-infiltrating lymphocytes",
author = "Belal Chaudhary and Eyad Elkord",
year = "2015",
month = "2",
day = "1",
doi = "10.1517/14728222.2014.977784",
language = "English",
volume = "19",
pages = "147--161",
journal = "Expert Opinion on Therapeutic Targets",
issn = "1472-8222",
publisher = "Informa Healthcare",
number = "2",

}

TY - JOUR

T1 - Novel expression of Neuropilin 1 on human tumor-infiltrating lymphocytes in colorectal cancer liver metastases

AU - Chaudhary, Belal

AU - Elkord, Eyad

PY - 2015/2/1

Y1 - 2015/2/1

N2 - Objectives: Neuropilin 1 (NRP1) is a transmembrane protein with diverse roles in physiological and pathological settings. NRP1 expression has been reported on T cells in inflammatory microenvironments and in secondary lymphoid tissue. Tumor-infiltrating lymphocytes (TILs) play an important role in cancer prognosis. In this study, we investigated NRP1 expression on TILs and peripheral blood mononuclear cells (PBMCs) from colorectal cancer liver metastases (LI/CRC). Methods: TILs from LI/CRC and PBMCs from healthy donors and patients were analyzed for expression of NRP1, in addition to other Treg-related markers. PBMCs were co-cultured in vitro with tumor tissue and analyzed for NRP1 expression. Results: We report for the first time that NRP1 is highly expressed on CD3+CD4+ TILs compared to PBMCs. NRP1 expression correlated closely with CD25 expression in TILs. NRP1 was expressed on both Helios+ and Helios- FoxP3-expressing Tregs and on a FoxP3-Helios- T cell subset. It was also induced on PBMCs following in vitro co-culture with tumor tissue. Conclusions: NRP1 is upregulated on TILs and can be induced on PBMCs by tumor tissue. Further studies are warranted to define the function of NRP1 on human TILs. As a therapeutic target, NRP1 may allow selective targeting of TIL subsets including suppressive Tregs.

AB - Objectives: Neuropilin 1 (NRP1) is a transmembrane protein with diverse roles in physiological and pathological settings. NRP1 expression has been reported on T cells in inflammatory microenvironments and in secondary lymphoid tissue. Tumor-infiltrating lymphocytes (TILs) play an important role in cancer prognosis. In this study, we investigated NRP1 expression on TILs and peripheral blood mononuclear cells (PBMCs) from colorectal cancer liver metastases (LI/CRC). Methods: TILs from LI/CRC and PBMCs from healthy donors and patients were analyzed for expression of NRP1, in addition to other Treg-related markers. PBMCs were co-cultured in vitro with tumor tissue and analyzed for NRP1 expression. Results: We report for the first time that NRP1 is highly expressed on CD3+CD4+ TILs compared to PBMCs. NRP1 expression correlated closely with CD25 expression in TILs. NRP1 was expressed on both Helios+ and Helios- FoxP3-expressing Tregs and on a FoxP3-Helios- T cell subset. It was also induced on PBMCs following in vitro co-culture with tumor tissue. Conclusions: NRP1 is upregulated on TILs and can be induced on PBMCs by tumor tissue. Further studies are warranted to define the function of NRP1 on human TILs. As a therapeutic target, NRP1 may allow selective targeting of TIL subsets including suppressive Tregs.

KW - Colorectal cancer liver metastases

KW - Expression

KW - Neuropilin 1

KW - Regulatory T cells

KW - Tumor-infiltrating lymphocytes

UR - http://www.scopus.com/inward/record.url?scp=84921282496&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84921282496&partnerID=8YFLogxK

U2 - 10.1517/14728222.2014.977784

DO - 10.1517/14728222.2014.977784

M3 - Article

VL - 19

SP - 147

EP - 161

JO - Expert Opinion on Therapeutic Targets

JF - Expert Opinion on Therapeutic Targets

SN - 1472-8222

IS - 2

ER -